HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$2.56
Day range
$2.56 - $2.67
Year range
$1.91 - $29.56
Market cap
95.18M USD
Avg Volume
428.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 376.00K | 57.98% |
Operating expense | 19.54M | -63.22% |
Net income | -22.26M | 59.39% |
Net profit margin | -5.92K | 74.30% |
Earnings per share | -0.76 | 61.03% |
EBITDA | -19.80M | 62.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.22M | -66.33% |
Total assets | 73.70M | -64.20% |
Total liabilities | 130.21M | 0.88% |
Total equity | -56.51M | — |
Shares outstanding | 30.58M | — |
Price to book | -1.35 | — |
Return on assets | -57.06% | — |
Return on capital | -95.34% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -22.26M | 59.39% |
Cash from operations | -26.86M | 30.48% |
Cash from investing | 0.00 | — |
Cash from financing | 2.12M | 4,146.00% |
Net change in cash | -24.74M | 35.89% |
Free cash flow | -20.88M | -4.93% |
About
Founded
2017
Headquarters
Website
Employees
74